Cohort Study of HIV-1 Incidence Among Clients of the Thai Red Cross AIDS Research Center, Bangkok, Thailand
NCT00713531 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 992
Last updated 2015-05-28
Summary
The purpose of this study is to assess populations in Thailand at high risk for HIV-1 infection for potential efficacy trials of candidate HIV vaccines to include:
1. assess incidence of HIV-1 and volunteer retention
2. describe early viral load and CD4 counts
3. assess participant willingness to participate in HIV vaccine efficacy trials and other HIV prevention trials
4. describe volunteer risk behavior
Conditions
- HIV Infections
Sponsors & Collaborators
-
SEARCH Research Foundation
lead OTHER
Principal Investigators
-
Nittay - Phanuphak, MD. · The Thai Red Cross AIDS Research Centre, Bangkok, Thailand
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-07-31
- Primary Completion
- 2009-12-31
- Completion
- 2010-06-30
Countries
- Thailand
Study Locations
More Related Trials
-
Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV
NCT00329251 ·Status: COMPLETED ·Phase: PHASE4
-
Immune Responses and Immunological Tolerance After Rabies Booster Vaccination in HIV-infected Adults
NCT03228069 ·Status: UNKNOWN ·Phase: NA
-
Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults
NCT00071851 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study on Anal Human Papillomavirus Infection and Anal Intraepithelial Neoplasia Among Men Who Have Sex With Men in Indonesia, Malaysia, and Thailand
NCT02155231 ·Status: COMPLETED
-
Safety Study of IL-7 in HIV-infected Patients (Inspire)
NCT00477321 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety Trial of the HIV-1 Tat Vaccine
NCT00751595 ·Status: COMPLETED ·Phase: PHASE2
-
Screening HIV-Infected Patients for Vaccine Studies
NCT00051519 ·Status: COMPLETED
-
A Study to Test Three Experimental HIV Vaccines in Healthy Adults.
NCT04553016 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluating the Safety and Pharmacokinetics of VRC07-523LS in the Sera and Mucosae of Healthy, HIV-Uninfected Adult Participants
NCT03735849 ·Status: COMPLETED ·Phase: PHASE1
-
HIV Vaccine Study in HIV Positive Patients
NCT01071031 ·Status: COMPLETED ·Phase: PHASE1
-
Use of Amphetamine-type Stimulants & Its Relationship With HIV Incidence and Antiretroviral Adherence Among MSM and TG
NCT03198962 ·Status: COMPLETED
-
Vienna HIV Infection Via Sex Study
NCT05326061 ·Status: RECRUITING
-
Anal HPV Infection and Risk for Anal High-grade Squamous Intraepithelial Lesion Among Thai MSM With Acute HIV Infection
NCT03032575 ·Status: COMPLETED ·Phase: NA
-
Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years Old
NCT00814762 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand
NCT00006327 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral Therapy
NCT03208231 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Therapeutic Efficacy of the VRC01 Antibody in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV Infection
NCT02664415 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Prepare for Future HIV Vaccine Studies
NCT00029744 ·Status: COMPLETED
-
Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People
NCT06576024 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Effects of Using Prime-boost HIVIS DNA and MVA-CMDR Vaccine Regimens With or Without Toll-like Receptor 4 Agonist on HIV Reservoirs in Perinatally HIV Infected Children and Youth
NCT04301154 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection in Women
NCT02568215 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers
NCT00083330 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV
NCT05085145 ·Status: UNKNOWN ·Phase: PHASE4
-
Radiopaque Matrix MK-8591 Implant in Participants at Low-Risk for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591-043)
NCT05115838 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV Vaccine
NCT01320176 ·Status: COMPLETED ·Phase: PHASE1